1,598.26 million is the present research & development by business enterprise, pharmaceutical industry in current ppp $ value in Denmark, reflecting an increase of 265.36 million (19.9%) since 2019.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Denmark
No matching regions
Similar regions to Denmark
Business R&D pharmaceutical in current PPP $
More indicators for Denmark
Government R&D in security as % of government support
0.32%
+0.02%
(2021)
Higher-education-finacing R&D financed by general university in local currency
129,580.00M
+1,780.00M
(2020)
R&D financed by rest of the world in local currency
37,780.00M
-21,180.00M
(2019)
Government R&D financed by rest of the world in local currency
2,450.00M
-310.00M
(2020)
Business R&D financed by rest of the world in local currency
12,950.00M
-22,140.00M
(2019)
Non-profit R&D growth rate
-20.37%
-18.37%
(2022)
Denmark Business R&D pharmaceutical in current PPP $ between 2009 and 2020
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2020 | 1,598.26M | +265.36M |
| 2019 | 1,332.90M | -43.29M |
| 2018 | 1,376.19M | -31.18M |
| 2017 | 1,407.37M | -77.45M |
| 2016 | 1,484.82M | +246.14M |
| 2015 | 1,238.68M | +76.12M |
| 2014 | 1,162.56M | +35.40M |
| 2013 | 1,127.16M | +61.33M |
| 2012 | 1,065.83M | +173.62M |
| 2011 | 892.21M | -38.16M |
| 2010 | 930.37M | +83.43M |
| 2009 | 846.94M |